Recap: CASI Pharmaceuticals Q4 Earnings
Recap: CASI Pharmaceuticals Q4 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.
卡西制药（纳斯达克股票代码：CASI）于2024年3月28日星期四上午7点公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
CASI Pharmaceuticals missed estimated earnings by -88.0%, reporting an EPS of $-0.45 versus an estimate of $-0.24.
CASI Pharmicals未达到预期收益-88.0％，每股收益为-0.45美元，而预期为-0.24美元。
Revenue was down $8.38 million from the same period last year.
收入比去年同期下降了838万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.21 which was followed by a 3.0% drop in the share price the next day.
上个季度，该公司的每股收益高出0.21美元，随后第二天股价下跌了3.0％。
Here's a look at CASI Pharmaceuticals's past performance:
以下是CASI Pharmicals过去的表现：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.56 | -0.50 | -0.64 | -0.37 |
| EPS Actual | -0.35 | -0.77 | -0.45 | -1.44 |
| Revenue Estimate | 10.40M | 10.09M | 9.10M | 10.79M |
| Revenue Actual | 8.84M | 9.82M | 8.35M | 15.26M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.56 | -0.50 | -0.64 | -0.37 |
| 实际每股收益 | -0.35 | -0.77 | -0.45 | -1.44 |
| 收入估算 | 10.40 米 | 10.09 亿 | 9.10 米 | 10.79 亿 |
| 实际收入 | 8.84 亿 | 9.82 米 | 8.35M | 15.26 亿 |
To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.
要追踪CASI制药公司发布的所有财报，请在此处访问其财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。